Identification of a novel class of androgen receptor antagonists based on the bicyclic-1H-isoindole-1,3(2H)-dione nucleus
- 11 November 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (2) , 389-393
- https://doi.org/10.1016/j.bmcl.2004.10.051
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Molecular determinants of resistance to antiandrogen therapyNature Medicine, 2003
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Dehydroepiandrosterone Activates Mutant Androgen Receptors Expressed in the Androgen-Dependent Human Prostate Cancer Xenograft CWR22 and LNCaP CellsMolecular Endocrinology, 1997
- Current status of combined androgen blockade: optimal therapy for advanced prostate cancer [published erratum appears in J Clin Endocrinol Metab 1995 Jul;80(7):2056]Journal of Clinical Endocrinology & Metabolism, 1995
- Antiproliferative activity of casodex (ICI 176.334) in hormone-dependent tumoursZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- Androgen receptor gene mutations in human prostate cancer.Proceedings of the National Academy of Sciences, 1992
- The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogensThe Journal of Steroid Biochemistry and Molecular Biology, 1992
- Non-steroidal antiandrogens. Design of novel compounds based on an infrared study of the dominant conformation and hydrogen-bonding properties of a series of anilide antiandrogensJournal of Medicinal Chemistry, 1991
- Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilidesJournal of Medicinal Chemistry, 1988
- Flutamide in the Treatment of Metastatic Carcinoma of the ProstateBritish Journal of Urology, 1981